Information:
Fel:
ID
34555
Beskrivning
A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis; ODM derived from: https://clinicaltrials.gov/show/NCT01251120
Länk
https://clinicaltrials.gov/show/NCT01251120
Nyckelord
Versioner (1)
- 2019-01-19 2019-01-19 -
Rättsinnehavare
see on clinicaltrials.gov
Uppladdad den
19 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Rheumatoid Arthritis NCT01251120
Eligibility Rheumatoid Arthritis NCT01251120
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01251120
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
ID.1
Item
adult patients, over the age of 18 years
boolean
ID.2
Item
diagnosis of moderate-to-severe active early rheumatoid arthritis (ra) of less than 2 years duration
boolean
ID.3
Item
das28 >3.2
boolean
ID.4
Item
swollen joint count (sjc) >/=6 (66 joint count), and tender joint count (tjc) >/=6 (68 joint count)
boolean
ID.5
Item
patients who have received dmards (including methotrexate) for 3-7 months
boolean
ID.6
Item
major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months after baseline
boolean
ID.7
Item
rheumatic autoimmune disease other than rheumatoid arthritis (secondary sjögrens syndrome or nodulosis with ra is permitted)
boolean
ID.8
Item
functional class iii or iv as defined by acr classification of functional status in rheumatoid arthritis
boolean
ID.9
Item
prior history of or current inflammatory joint disease other than ra
boolean